Gland Pharma Limited
GLAND
Rang în acțiuni
#3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Preț acțiune
$32.32
Capitalizare de piață
$5.33B
Schimbare (1 zi)
-3.01%
Schimbare (1 an)
47.99%
Țară
IN
Tranzacționează Gland Pharma Limited (GLAND)
Categorie
Healthcare
Raport P/B pentru Gland Pharma Limited (GLAND)
Raport P/B la data de October 2026 TTM: 4.84
Conform celor mai recente rapoarte financiare și prețului acțiunilor Gland Pharma Limited, raportul P/B actual (TTM) este 4.84. La sfârșitul anului 2024, compania avea un P/B de 3.43.
Istoricul raportului P/B pentru Gland Pharma Limited din 2017 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 4.84 | 72.92% |
| 2025 | 2.80 | -18.34% |
| 2024 | 3.43 | 30.55% |
| 2023 | 2.62 | -65.05% |
| 2022 | 7.51 | 13.10% |
| 2021 | 6.64 | -14.17% |
| 2020 | 7.73 | -25.51% |
| 2019 | 10.38 | -15.78% |
| 2018 | 12.33 | -8.64% |
| 2017 | 13.49 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 4.11% |
IN
|
